Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
874 studies found for:    Open Studies | "Carcinoma, Non-Small-Cell Lung"
Show Display Options
Rank Status Study
21 Not yet recruiting Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: T cells
22 Recruiting Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Apatinib;   Drug: Placebo
23 Recruiting Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: nab-paclitaxel IV;   Drug: CC-486;   Drug: Duravalumab
24 Recruiting MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MK-3475;   Drug: Gemcitabine
25 Recruiting Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Genetic: Genomic profile by FoundationOne;   Genetic: Genomic profile by other methods
26 Recruiting Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cyclophosphamide;   Biological: DRibble vaccine;   Drug: Imiquimod;   Drug: GM-CSF;   Biological: HPV vaccine
27 Recruiting Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MPDL3280A;   Drug: Carboplatin;   Drug: Nab-paclitaxel
28 Recruiting Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Radiation Therapy;   Radiation: Conventional radiation
29 Recruiting Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: Group 1: Peripherally Located Tumors;   Radiation: Group 2: Peripherally Located Chest Wall Adjacent Tumors;   Radiation: Group 3: Centrally Located Tumors
30 Recruiting Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
Condition: Non-small Cell Lung Cancer
Interventions: Other: clinical observation;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy
31 Recruiting A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: INC280 single agent;   Drug: INC280 in combination with erlotinib;   Drug: Platinum/pemetrexed
32 Recruiting Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers
Conditions: Carcinoma, Non-Small Cell Lung;   EGFR Gene Mutation
Intervention: Drug: Gemcitabine platinum combined with erlotinib
33 Recruiting Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Condition: Squamous Cell Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Abraxane (Induction);   Drug: Carboplatin (Induction);   Drug: Abraxane (Maintenance);   Other: Best Supportive Care (Maintenance)
34 Recruiting VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: treatment
35 Recruiting ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Advanced Non-small Cell Lung Cancer
Intervention: Drug: ONO-4538
36 Recruiting Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FKB238 (bevacizumab);   Drug: Avastin (bevacizumab);   Drug: Paclitaxel;   Drug: Carboplatin
37 Recruiting Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma
Intervention: Drug: Chemotherapy
38 Not yet recruiting 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
Condition: Non-small-cell Lung Cancer
Intervention: Radiation: 18F-FDG
39 Recruiting The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Apatinib;   Drug: Etoposide
40 Recruiting An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients
Condition: Non-Small Cell Lung Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.